🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study incorporating brentuximab vedotin and dose attenuated ritux...
Status
Active Not Recruiting
Location
James P. Wilmot Cancer Institute, University of Rochester Medical Center
Start Date
2016-06
Trial ID
NCT02734771
Treatments Being Tested
There is no data comparing the effectiveness of the 4 most relevant first-l...
Status
Enrolling By Invitation
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT07258680
Treatments Being Tested
This study will use a combination of Brentuximab vedotin with CHP to treat ...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-02-10
Trial ID
NCT05673785
Treatments Being Tested
Systemic Anaplastic Large Cell Lymphomas (sALCL) are rare lymphomas for whi...
Status
Not Yet Recruiting
Location
A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Start Date
2026-05
Trial ID
NCT07467317
Evaluation of the Safety and Efficacy of Brentuximab Vedotin Combined With ...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2025-09
Trial ID
NCT06925555
Treatments Being Tested
This is a double-blind, randomized, multicenter, phase 3 clinical trial to ...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2013-01-31
Trial ID
NCT01777152
Treatments Being Tested
It has been recently reported that EATL type 1, but not refractory coeliac ...
Status
Completed
Location
Hopital Necker - Enfants malades
Start Date
2018-02-07
Trial ID
NCT03217643
Treatments Being Tested
Peripheral T-cell lymphoma (PTCL) encompasses a broad range of post-thymic ...
Status
Recruiting
Location
Chu D'Amiens - Hopital Sud
Start Date
2022-08-01
Trial ID
NCT05444712
Treatments Being Tested
This phase II trial studies the side effects and how well brentuximab vedot...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2017-05-25
Trial ID
NCT03113500
The goal of this observational study is to evaluate how well brentuximab ve...
Status
Recruiting
Location
Hospital Universitario A Coruña
Start Date
2026-02-15
Trial ID
NCT07624838
Treatments Being Tested